FDA-Approved Weight Loss Drugs in 2026: Complete Guide for Everyone

FDA-approved weight loss drugs are transforming the way doctors treat obesity and excess weight. Imagine a medication that not only controls your appetite but also delivers clinically proven weight loss of up to 21% of your body weight, the newest generation of prescription weight loss drugs does exactly that.

FDA-approved weight loss medications have come a long way since 2012. The journey began with liraglutide (Saxenda), the first GLP-1 drug officially approved for obesity treatment. Then came semaglutide (Wegovy) in 2021, followed by tirzepatide (Zepbound) in 2023 – the most effective option available today. And as of April 1, 2026, the FDA approved Foundayo (orforglipron), a once-daily pill with no food or water restrictions, making it the most flexible oral option on the market.

Today, accessing these medications is easier than ever. The affordable GLP-1 weight loss without insurance can connect you directly with licensed doctors who can evaluate your eligibility, write your prescription and have your medication delivered straight to your door, all without a single waiting room visit.

Today, millions of people are turning to online telehealth programs for affordable access to these medications, with licensed doctor guidance and safe prescriptions delivered to their door. If you’re ready to explore your options, check our guide to the best online GLP-1 providers offering doctor-supervised programs that prescribe semaglutide and tirzepatide from licensed U.S. pharmacies.

Since many people search for a complete weight loss medications list to compare drugs, results, and prices, we’ve created a full breakdown of every FDA-approved weight loss drug currently available. To make this guide even more useful, we’ve included brand-name versus compounded medication costs, so you can see exactly how much you can save whether you have insurance or not.

Before we dive into each drug in detail, here’s a quick snapshot giving you an overview of all 7 FDA-approved options, their clinical results, and how brand versus compounded prices compare.

What Is GLP-1 Medication and How Does It Work?

Your body already makes GLP-1 naturally. Glucagon-like peptide-1 is a hormone your gut releases after you eat – it tells your brain you’re full, slows down digestion, and signals your pancreas to release insulin when blood sugar rises. The problem is, for many people struggling with obesity, this signal is too weak or fades too quickly.

GLP-1 medication works by mimicking that natural hormone, but stronger and longer-lasting. GLP-1 receptor agonists essentially keep that “I’m full” signal running far longer than your body would on its own – so you eat less, crave less, and lose weight more consistently over time.

The main FDA-approved GLP-1 drugs you’ll hear about are Wegovy and Ozempic (both semaglutide) and Zepbound and Mounjaro (both tirzepatide). Wegovy and Zepbound are specifically approved for weight loss. Ozempic and Mounjaro are approved for type 2 diabetes – though many doctors prescribe them off-label for weight management too.

Clinical trials show patients lose between 14% and 22% of their total body weight on these medications – numbers that diet and exercise alone rarely come close to matching.

Why Are FDA-Approved Weight Loss Drugs Important?

According to the CDC, more than 2 in 5 U.S. adults currently live with obesity, and the condition costs the American healthcare system nearly $173 billion every single year.

But obesity is not just a number on a scale. It is a recognized medical condition directly linked to high blood pressure, type 2 diabetes, heart disease, obstructive sleep apnea and certain cancers including breast, colon and kidney. These are not minor inconveniences. They are some of the leading causes of preventable death in the United States.

This is exactly why FDA approval matters. When a FDA-Approved weight loss drug earns FDA approval, it has gone through years of safety testing, large scale clinical efficacy trials and regulated dosing standards. That is a very different standard than the supplements and OTC weight loss pills sitting on pharmacy shelves, which are not reviewed by the FDA before they go on sale.

So who should consider prescription weight loss drugs? Generally, anyone with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight related condition, is a candidate worth discussing with their doctor.

5 Famous FDA-Approved Weight Loss Drugs

Zepbound (Tirzepatide) — Most potent FDA-Approved Injection for Weight Loss (Editor’s Pick)

Zepbound is hands down the most effective FDA-approved weight loss drug available right now. Approved by the FDA on November 8, 2023, this once-weekly injection from Eli Lilly has set a new standard for what prescription weight loss drugs can actually deliver.

What makes Zepbound different from every other option on this list is its dual mechanism. Most GLP-1 medications work on one hormone receptor. Zepbound works on two – it activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors at the same time.

These two hormones work together to reduce hunger, slow digestion, balance blood sugar and promote steady long-term fat loss. That combination is why many experts now consider tirzepatide the most reliable GLP-1 for weight loss based on current clinical evidence.

Zepbound contains tirzepatide, the exact same active ingredient found in Mounjaro. The difference is purpose. Mounjaro is approved for type 2 diabetes. Zepbound is specifically approved for chronic weight management and moderate to severe obstructive sleep apnea in adults with obesity – making it the first FDA-approved prescription treatment for sleep apnea ever approved.

The clinical results are genuinely impressive. In the SURMOUNT-1 trial, patients using the highest 15 mg dose lost an average of 21% of their body weight – roughly 48 pounds – over 72 weeks.

This makes Zepbound one of the most effective appetite suppressants that work for long-term weight management, not just for obesity but for the serious health conditions that come with it.

Approved for: Adults with obesity (BMI 30 or higher) or adults who are overweight (BMI 27 or higher) with at least one weight related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnea.

How it works: Zepbound targets two hormones simultaneously GIP and GLP-1 to reduce hunger, slow stomach emptying and help users feel full for longer periods between meals.

Do not take if: You are pregnant, breastfeeding, or have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Side effects: The most common side effects include nausea, vomiting, diarrhea, constipation and stomach discomfort. These are typically dose-dependent and improve as your body adjusts over the first few weeks. Rare but serious side effects reported in studies include pancreatitis and gallbladder problems.

Zepbound Dosing Schedule and How to Inject

Zepbound is given as a once-weekly subcutaneous injection using a pre-filled single-dose pen. You inject it under the skin of your abdomen, thigh or upper arm. Your doctor will start you on a low dose and gradually increase it every four weeks as your body adjusts. The dose escalation schedule typically runs from 2.5 mg up to a maximum of 15 mg weekly, depending on your response and tolerance.

Zepbound vs Wegovy – Which Is More Effective?

The SURMOUNT-5 trial answered this question directly for the first time. Patients on Zepbound lost an average of 20.2% of their body weight compared to 13.7% for those on Wegovy – a difference of more than 6 percentage points in a controlled clinical setting.

Both drugs work well, but if maximum weight loss is the goal and your doctor agrees you are a good candidate, the current clinical evidence places Zepbound ahead. You can read the full comparison in our guide to the best GLP-1 for weight loss.

👉 Get Tirzepatide GLP-1 medication – Get $120 off – Now!→

Wegovy (Semaglutide) — FDA-Approved GLP-1 for Lasting Weight Management (Approved 2021)

Wegovy is the gold standard of prescription weight loss medications and for good reason. Approved by the FDA in June 2021, this once-weekly semaglutide injection from Novo Nordisk has helped millions of adults finally achieve real, lasting weight loss after years of struggling.

The STEP trial results are difficult to argue with. Patients lost an average of 14.9% of their body weight at 68 weeks compared to just 2.4% on placebo. And Wegovy keeps getting better. The new Wegovy pill, FDA-approved in December 2025, delivered 16.6% weight loss at 64 weeks with one in three patients losing 20% or more of their body weight.

Wegovy is also approved for cardiovascular risk reduction, MASH liver disease and weight management in teenagers aged 12 and older – making it one of the most versatile and clinically proven weight loss drugs available today.

Foundayo (Orforglipron) – The Newest FDA-Approved GLP-1 Pill for Weight Loss

If you have been waiting for a weight loss pill that actually fits into a real daily routine, Foundayo might be exactly what you have been looking for.

Foundayo (orforglipron) became the newest FDA-approved weight loss drug on April 1, 2026, manufactured by Eli Lilly. What makes it genuinely different from every other GLP-1 option on this list is simple. You can take it any time of day, with or without food, with or without water. No empty stomach requirement. No morning routine restrictions. Just one pill, once daily, whenever it suits you.

That is a meaningful advantage over the Wegovy pill, which must be taken first thing in the morning on an empty stomach with no more than four ounces of water.

Foundayo is a non-peptide small molecule GLP-1 receptor agonist, which means your body absorbs it more easily than traditional peptide-based injections. In the ATTAIN-1 clinical trial, patients on the highest dose lost an average of 12.4% of their body weight, roughly 27 pounds, over 72 weeks.

Cost is another area where Foundayo stands out. It starts at just $25 per month through LillyDirect, making it one of the most affordable FDA-approved weight loss medications currently available. Prescriptions were accepted from April 6, 2026 with free home delivery included.

Saxenda (Liraglutide) — FDA-Approved Daily GLP-1 Injection for Adults and Teens

Saxenda was the drug that started it all. Before Wegovy and Zepbound existed, liraglutide was the go-to FDA-approved weight loss injection for adults and teenagers aged 12 and older weighing more than 132 pounds.

In a 56-week clinical study, 62% of Saxenda patients lost 5% or more of their body weight real, measurable results for people who had tried everything else. It is a once-daily injection taken in the abdomen, thigh or upper arm, making it simple to self-administer at home.

The best news for budget-conscious patients came in December 2024 when the FDA approved a generic liraglutide option, bringing the cost down significantly and making this proven treatment more accessible than ever before.

Saxenda is still very much available, still clinically proven and now more affordable than at any point in its history.

Contrave (Bupropion / Naltrexone) – Best Non-GLP-1 Oral Weight Loss Pill

Not everyone wants injections. If you are looking for a proven prescription weight loss pill that requires no needles and no weekly shots, Contrave is worth serious consideration.

Contrave combines two already-trusted medications – bupropion, an antidepressant, and naltrexone, an opioid blocker – and together they target two separate areas of the brain responsible for hunger and food cravings. It is not a stimulant and it is not a controlled substance, which makes it a more accessible option for many patients.

The clinical results are convincing. In studies, 42% of Contrave patients lost 5% or more of their body weight compared to just 17% on placebo.

One important warning – Contrave contains bupropion and cannot be used by anyone with a seizure disorder. If you have no seizure history and prefer an oral pill over GLP-1 injections, Contrave is a strong candidate to discuss with your doctor.

Qsymia (Phentermine / Topiramate) – Oral Combination Pill for Adults and Teens 12+

Qsymia is one of the most clinically effective oral weight loss pills available today and it works without any injections whatsoever.

This FDA-approved combination pill pairs phentermine, a proven appetite suppressant, with extended-release topiramate, which helps you feel fuller for longer after meals. The results speak clearly. Patients lost between 11.2 and 24 pounds on average within one year, and 47% of patients on the highest dose lost 10% or more of their body weight compared to just 7% on placebo.

Qsymia is approved for adults and teenagers aged 12 and older, and a generic version is now available making it one of the most affordable prescription weight loss options on the market today.

Qsymia is a CIV controlled substance and should always be taken in the morning. Never stop it abruptly without talking to your doctor first.

What Is BMI and Do You Qualify for Weight Loss Medication?

BMI stands for body mass index and it gives doctors a simple way to assess your weight relative to your height. You calculate it by dividing your weight in kilograms by your height in meters squared.

Here is what the numbers mean:

• BMI 18.5 to 24.9 – healthy weight
• BMI 25 to 29.9 -overweight
• BMI 30 and above – obese

Most FDA-approved weight loss medications become available to you once your BMI reaches 30 or higher. If your BMI sits at 27 or above and you have at least one weight related condition such as high blood pressure, type 2 diabetes or sleep apnea, you also qualify.

Teenagers aged 12 and older can qualify for certain medications including Wegovy, Saxenda and Qsymia depending on their BMI percentile for age and sex.

Your healthcare provider makes the final eligibility decision based on your full health picture, not just your BMI number alone.

Ozempic, Mounjaro and Rybelsus – What About Off-Label Weight Loss Options?

Here is something that confuses a lot of people. Ozempic and Mounjaro are not FDA-approved for weight loss. Both drugs are officially approved for type 2 diabetes management. However, many clinicians do prescribe them off-label for weight loss when they feel it is appropriate for their patient.

The connection is straightforward. Ozempic contains semaglutide, the exact same active ingredient as Wegovy, just at different doses. Mounjaro contains tirzepatide, the same ingredient found in Zepbound, again at different doses. Rybelsus is an oral semaglutide tablet approved for diabetes only.

Doctors prescribing these off-label have clinical results to support their decision. Ozempic studies show patients losing 8 to 14 pounds on average. Mounjaro studies show 12 to 25 pounds lost over 52 weeks.

The catch is insurance. Most insurers will not cover off-label prescriptions for weight loss, meaning you pay full price out of pocket. Always ask your clinician about FDA-approved alternatives like Wegovy or Zepbound first, as these carry stronger coverage eligibility and clearer weight loss approvals.

Prescription Weight Loss Drugs Safety and Side Effects

Every FDA-approved weight loss drug on this list has gone through rigorous clinical safety testing before reaching patients. That is exactly what FDA approval means. But like any medication, side effects are possible and knowing what to expect makes the experience far easier to manage.

The good news is that most side effects are mild, temporary and significantly reduce as your body adjusts to the medication over the first few weeks.

Common Side Effects – What to Expect in Week 1

The most frequently reported side effects across GLP-1 drugs including Wegovy, Zepbound, Saxenda and Foundayo are nausea, vomiting, diarrhea and constipation. These are directly related to how the drug slows digestion and they are almost always dose dependent.

Your clinician will start you on the lowest dose and increase gradually, which is specifically designed to minimize these early discomforts and give your body time to adjust comfortably.

Serious Side Effects – When to Call Your Doctor

Serious side effects are rare but worth knowing. These include pancreatitis, gallbladder disease and a potential thyroid tumor risk identified in animal studies only, not confirmed in humans. Contrave and Qsymia carry an additional seizure risk for certain patients. Always tell your prescribing clinician about any unusual symptoms immediately, and never adjust your dose without medical guidance.

Who Should Avoid Prescription Medications for Weight Management

Prescription weight loss medications are not the right fit for everyone and that is completely okay. Knowing who should avoid these drugs is just as important as knowing who benefits from them.

GLP-1 drugs including Wegovy, Zepbound, Saxenda and Foundayo are not recommended if you are pregnant, breastfeeding, or have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. Anyone with a history of pancreatitis should also discuss this carefully with their clinician before starting.

Contrave should be avoided by anyone with a seizure disorder, uncontrolled high blood pressure or a history of eating disorders.

Qsymia is not safe during pregnancy due to a confirmed birth defect risk, and should also be avoided by anyone with glaucoma.

As a general rule, anyone under 18 should only use medications specifically approved for their age group.

The most important thing to remember is that your clinician reviews your complete health history before prescribing anything, making sure the right drug is matched to the right person every single time.

Here is your Comparison Chart section — 200 words, human tone, with table:

FDA-Approved Weight Loss Drugs Comparison Chart — Effectiveness, Cost and Form

Finding the right weight loss drug comes down to three things – how effective it is, what form works for your lifestyle, and what you can realistically afford. This comparison covers all 7 FDA-approved options side by side so you can make a genuinely informed decision.

Drug	Form	Avg Weight Loss	Approved Age	Monthly Cost
Zepbound	Injection	21%	18+	$500–$1,100
Wegovy	Injection + Pill	14.9–21%	12+	$299–$1,300
Foundayo	Pill	12.4%	18+	From $25
Saxenda	Injection	4.5%	12+	$370–$900
Contrave	Pill	4–5%	18+	$180–$400
Qsymia	Pill	5–10%	12+	$90–$200
Alli/Xenical	Pill	3–5%	18+	$50–$180

Three things stand out clearly from this data. Zepbound delivers the highest average weight loss of any FDA-approved drug currently available. Foundayo is the most affordable at just $25 per month through LillyDirect, making it the most accessible entry point for patients without insurance. Wegovy is the most versatile, carrying additional approvals for cardiovascular risk reduction, MASH liver disease and weight management in teenagers aged 12 and older.

Are OTC Herbal Weight Loss Supplements FDA-Approved? (Short Answer: No)

If you have ever stood in a pharmacy aisle tempted by a bottle promising rapid weight loss with all-natural ingredients, here is what you need to know before buying anything.

OTC herbal and dietary supplements are not reviewed or approved by the FDA before they go on sale. That means no mandatory safety testing, no efficacy trials and no regulated dosing standards. Any manufacturer can put almost anything in a bottle and market it for weight loss.

The risks are real. The FDA banned ephedra in 2004 after it was directly linked to heart attacks, strokes and seizures in users. That product sat on shelves for years before action was taken.

Common supplements marketed for weight loss today include chromium, green tea extract, hoodia and guar gum. None of these have strong clinical evidence supporting meaningful weight loss in humans.

Never combine any OTC supplement with a prescription weight loss drug without speaking to your clinician first. The interaction risks are simply not worth it when proven, FDA-approved options are now more accessible and affordable than ever before.

Frequently Asked Questions About FDA-Approved Weight Loss Drugs

What is the newest FDA-approved weight loss drug?

The newest FDA-approved weight loss drug is Foundayo (orforglipron), approved by the FDA on April 1, 2026. It is a once-daily oral pill manufactured by Eli Lilly that requires no food or water restrictions.

Which GLP-1 drug causes the most weight loss?

Zepbound (tirzepatide) currently produces the most weight loss of any FDA-approved drug, with patients losing an average of 21% of their body weight over 72 weeks in the SURMOUNT-1 clinical trial.

Can you get FDA-approved weight loss drugs online?

Yes. Licensed telehealth platforms connect you with qualified clinicians who can evaluate your eligibility, write a legal prescription and have your FDA-approved weight loss medication delivered directly to your door.

Does insurance cover FDA-approved weight loss drugs?

Insurance coverage varies significantly. Most plans do not cover weight loss drugs when prescribed for obesity alone. Coverage is more likely when the drug is prescribed for type 2 diabetes, heart disease or sleep apnea.

What happens when you stop weight loss medication?

Weight often returns after stopping prescription weight loss drugs. This is a biological response, not a personal failure. Most clinicians recommend long-term use combined with lifestyle changes to maintain results effectively.

How long does it take for weight loss drugs to work?

Most patients notice reduced appetite within the first few days. Measurable weight loss typically begins within the first four weeks, with the most significant results appearing between months three and six of consistent treatment.

Are FDA-approved weight loss drugs safe?

Yes, when prescribed and monitored by a licensed clinician. Every FDA-approved weight loss drug has passed large-scale clinical safety and efficacy trials. Side effects exist but are manageable and most resolve as your body adjusts to the medication.